Healthcare associated urinary tract infections: a protocol for a national point prevalence study
Brett Mitchell A B D , Anne Gardner B , Wendy Beckingham C and Oyebola Fasugba BA Faculty of Nursing and Health, Avondale College of Higher Education, Cooranbong, NSW 2265, Australia.
B School of Nursing, Midwifery and Paramedicine, Australian Catholic University, Fitzroy, Vic. 3065, Australia.
C Canberra Hospital and Health Services, Garran, ACT 2605, Australia.
D Corresponding author. Email: brett.mitchell@avondale.edu.au
Healthcare Infection 19(1) 26-31 https://doi.org/10.1071/HI13037
Submitted: 5 October 2013 Accepted: 20 November 2013 Published: 10 December 2013
Journal Compilation © Australasian College for Infection Prevention and Control 2014
Abstract
Background: Urinary tract infections account for ~30% of healthcare-associated infections reported by hospitals. Virtually all healthcare-associated urinary tract infections (HAUTIs) are caused by instrumentation of the urinary tract, creating an opportunity to prevent a large proportion of HAUTIs, including catheter-associated urinary tract infections (CAUTIs). In Australia, there is no specific national strategy and surveillance system in place to address HAUTIs or CAUTIs. To determine the need for prospective surveillance of HAUTIs, we propose undertaking a national point prevalence study. This paper describes the methods that could be used to undertake such a study.
Methods: A cross-sectional point prevalence design is proposed. The population is all patients hospitalised overnight in Australian hospitals, with the sample to exclude outpatients and those in emergency departments. The proposed operational definition is that used by the Health Protection Agency. A standardised training package for data collectors is recommended with standardised data collection and analysis processes described. Individual patient consent should be waived.
Discussion: Explanation of aspects of the proposed methods are provided, primarily based on findings from a pilot study that informed the development of the proposed protocol. This included development and delivery of training for data collectors and use of the Health Protection Agency HAUTI surveillance definition, rather than the Centers for Disease Control definition.
Conclusion: Conducting a national point prevalence study on HAUTIs including CAUTIs will provide evidence that can be subsequently used to debate the cost effectiveness and value of prospective surveillance. By conducting a pilot study and critically evaluating that process, we have been able to propose a method that could be used for a single hospital or national study.
References
[1] Health Protection Agency. Fourth National Point Prevalence Survey on Healthcare Associated Infections and First National Point Prevalence Survey on Antimicrobial Use and Quality Indicators in England. London: HPA; 2011. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296687778967 [verified November 2013][2] Smyth ETM, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, et al Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results. The Journal of Hospital Infection 2008; 69 230–248.
| Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1cngsVWnsA%3D%3D&md5=0fa22f31f44354a0c1a3f2bbb4c10569CAS |
[3] Lanini S, Jarvis WR, Nicastri E, Privitera G, Gesu G, Marchetti F, et al Healthcare‐Associated Infection in Italy: Annual Point‐Prevalence Surveys, 2002–2004. Infection Control and Hospital Epidemiology 2009; 30 659–665.
| Healthcare‐Associated Infection in Italy: Annual Point‐Prevalence Surveys, 2002–2004.Crossref | GoogleScholarGoogle Scholar | 19496645PubMed |
[4] World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. Geneva: WHO; 2011.
[5] Centers for Disease Control and Prevention. NHSN Patient Safety Component Manual. Atlanta, GA: CDC; 2012. Available from: http://www.cdc.gov/nhsn/pdfs/pscManual/7pscCAUTIcurrent.pdf [verified November 2013]
[6] Elvy J, Colville A. Catheter associated urinary tract infection: what is it, what causes it and how can we prevent it? Journal of Infection Prevention 2009; 10 36–41.
| Catheter associated urinary tract infection: what is it, what causes it and how can we prevent it?Crossref | GoogleScholarGoogle Scholar |
[7] Umscheid CA, Mitchell MD, Agarwal R, Williams K, Brennan PJ. Mortality from Reasonably-Preventable Hospital Acquired Infections. Arlington, VA: The Society for Healthcare Epidemology of America; 2008. Available from: http://www.shea-online.org/assets/files/0408_penn_study.pdf [verified November 2013]
[8] McLaws M-L, Gold J, King K, Irwig LM, Berry G. The prevalence of nosocomial and community-acquired infections in Australian hospitals. The Medical Journal of Australia 1988; 149 582–590.
| 1:STN:280:DyaL1M%2FntVemuw%3D%3D&md5=30896b3aa0416f1277228bcb5542934eCAS | 3143900PubMed |
[9] Graves N, Tong E, Morton AP, Halton K, Curtis M, Lairson D, et al Factors associated with health care-acquired urinary tract infection. American Journal of Infection Control 2007; 35 387–392.
| Factors associated with health care-acquired urinary tract infection.Crossref | GoogleScholarGoogle Scholar | 17660009PubMed |
[10] Magill SS, Hellinger W, Cohen J, Kay R, Bailey C, Boland B, et al Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infection Control and Hospital Epidemiology 2012; 33 283–291.
| Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida.Crossref | GoogleScholarGoogle Scholar | 22314066PubMed |
[11] Cruickshank M, Murphy C, eds. Reducing Harm to Patients from Healthcare Associated Infections: An Australian Infection Prevention and Control Model for Acute Hospitals. Sydney: Australian Commission on Safety and Quality in Health Care; 2009.
[12] The National Health and Medical Research Council, The Australian Research Council, The Australian Vice-Chancellors’ Committee. National Statement on Ethical Conduct in Human Research 2007 – Updated May 2013. Canberra: Commonwealth of Australia; 2013.
[13] Graves N, Halton K, Paterson D, Whitby M. Economic rationale for infection control in Australian hospitals. Healthcare Infection 2009; 14 81–88.
| Economic rationale for infection control in Australian hospitals.Crossref | GoogleScholarGoogle Scholar |
[14] Scottish Surveillance of Healthcare Associated Infection Programme. Catheter Associated Urinary Tract Infection Surveillance for Acute Settings. Glasgow: Health Protection Scotland; 2012.
